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Attention Deficit Disorder: An Overview 
Wiley C. Rasbury, PhD* 
There have always been and probably always will be children who are hyperactive, impulsive, inattentive, and distract-
ible. One of the first descriptions of such children was given by 
Dr George Still (1) in 1902 in his lecture to the Royal Academy 
of Physicians in London. In the past 80 years interest in the 
study of children with these behavior characteristics has grown 
with respect to the etiology, management, and outcome of their 
condition. 
More literature has been published on the group of behaviors 
now referred to as the attention deficit disorder (ADD) than on 
any other psychosocial problem in childhood. Approximately 
31 publications were written on the ADD between 1957 and 
1960, 2,000 between 1961 and 1976, 700 from 1977 to 1980 (2), 
and over 900 from 1981 through 1987. However, the.se statistics 
do not necessarily imply that the incidence of ADD is rising, and 
it is still impossible to make concrete epidemiological state-
ments given the lack of agreement on a definition of the condi-
tion. However, substantial evidence shows that some children 
are significantiy less atientive and more impulsive, distractible, 
and/or hyperactive than their peers and that such problems can 
interfere with their social, personal, and academic adjustment. 
No precise definition of the ADD exists, and we do not know 
whether or not such childhood behavioral problems are more 
common today than in the past. Neither do we know exactly 
what causes such behaviors, nor how to best manage and/or treat 
these children, although Ross and Ross (2) and Weiss and 
Hechtman (3) have addressed these issues. 
Definitions 
While there is some consensus on the behaviors of this disor-
der, ambiguity still exists. As Conners and Wells (4) noted: 
"The symptoms appear to come from the same pot, but are 
sometimes stirred a bit differently. The range of symptoms in-
volved seems for the most part to reflect a difference in emphasis 
rather than fundamental disagreement." In his review of over 
200 studies on the ADD, Barkley (5) found that over 70% failed 
to use any objective or specifiable criteria for diagnosis. The 
definition by the American Psychiatric Association (APA) (6) is 
based on a specific set of behaviors which includes most of those 
ofconcem to researchers and clinicians (Table I). Unfortunately, 
the APA definition, like most, lacks specificity regarding 
etiology, intensity of symptoms, pervasiveness, and numerous 
aspects of differential diagnosis and fails to clarify the defini-
tional picture of the disorder In clinical practice no universally 
agreed upon approach to diagnosis exists, but presumably most 
clinicians rely on their experience with children to render a diag-
nosis based on age of onset of symptoms, intensity, per-
vasiveness, duration of specific behaviors, and exclusion of 
other psychopathological and nonpsychopathological childhood 
conditions that can cause such behaviors. While clinicians use a 
variety of methods to diagnose this disorder, generally the fol-
lowing criteria are useful: 1) history; 2) behavioral ratings on 
standardized forms completed by parents and teachers; 3) 
clinical observations; and 4) psychological test performance, es-
pecially on tasks of attention/concentration and leaming (7). In 
the final analysis, an adequate or acceptable definition of the 
ADD will evolve slowly with continuing research. The opera-
tional definition offered by the APA, while not wholly accept-
able, does attempt to reflect knowledge gained from research in 
this area and therefore may be considered as an acceptable oper-
ational guideline subject to ongoing refinement. 
Prevalence 
Prevalence estimates of the ADD vary from 1% to 10% with an 
average of 5%; estimates are significantiy lower (typically 1% to 
1.5%) when diagnosis is based on agreement of multiple sources 
such as teachers, parents, physicians, or other clinicians (8). 
Male:female estimates have ranged from 3:1 to 9:1, with a mean 
of 6:1. Cross-cultural studies utilizing teacher ratings alone have 
revealed estimates of 12% to 18% (8). These higher estimates, 
assuming they are valid, probably represent a heterogeneous 
group of children with respect to the factors causing their behav-
ior, with a much smaller subset meeting a more rigorous defini-
tion of the disorder Also, such data reflect the potential danger 
in basing a diagnosis of ADD solely on teacher ratings, es-
pecially if medication is recommended as the primary treatment 
approach. Of the children referred to our clinic, 50% to 60% 
have teacher ratings suggesting the ADD, but no more than 2% 
to 3% of these children receive the diagnosis. 
Etiologic Speculations 
Lack of etiologic knowledge before the 1970s has been noted 
in various reviews (9), but much progress has been made in the 
last decade in identifying possible causes ofthis disorder While 
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views have shifted away from unifactorial to multifactorial 
causes, no proposed explanation for the condition has been uni-
versally or even consensually accepted by researchers and clini-
cians. Furthermore, a number of thought-provoking articles 
have questioned the utility and validity of the attention deficit 
concept (10,11). Various areas implicated as possible explana-
tions for the ADD, ranging from central nervous system damage 
to child-rearing practices, are discussed in the following 
sections. 
Central nervous system daniage 
While injury or infection of the central nervous system can 
produce either a transient or chronic ADD, such damage ac-
counts for no more than 5% of the children viewed as manifest-
ing these behaviors. Numerous studies of children diagnosed 
with the disorder report that approximately 50% had "soft" neu-
rological signs, but the etiologic relevance of these signs has 
been questioned. As Touwen and Sporrel (12) stated: "The at-
tempt to explain disorders of complex behavior only on the basis 
of neurological minor signs testifies to an objectionable kind of 
reductionism." 
Neuroanatomic 
Recent reviews (13,14) revealed no less than 11 different (in 
some cases overlapping) theories of the neuroanatomic basis of 
the disorder While none of these have gained significant em-
pirical support, the most intriguing theories postulate a rela-
tionship between various subcortical brain structures and the 
frontal lobes. 
Neurotransmitter 
Much interest has been placed on the role of dopamine and, to 
a lesser extent, of norepinephrine on the mediation of the ADD. 
Interest in these sympathomimetic amines largely stems from 
use of the stimulants methylphenidate hydrochloride, dex-
troamphetamine sulfate, and pemoline which affect the release 
and reuptake of dopamine and norepinephrine (15) and help to 
reduce attention deficit behaviors. Several reviews have been 
published on the role of neurotransmitters in this condition 
(13,14,16,17). Zametkin and Rapoport (13,14) attempted to inte-
grate neuroanatomic and neurotransmitter theories of attention 
deficit behavior. In general, as with neuroanatomic theories, 
there is no singulariy accepted biochemical theory of the disor-
der. Furthermore, given the status of this research, it is inap-
propriate for clinicians to tell parents or the affected child that 
the attention deficit behavior is the result of a "chemical im-
balance." Such statements are at best misleading and at worst 
counterproductive in the management of these patients. 
Genetic 
Genetic studies of families and adoptees provide some sup-
port for the possible genetic transmission of the ADD, but the 
research lacks sufficient scientific evidence (2). Researchers 
suspect that if the disorder is transmitted genetically, it is poly-
genetic in nature. One of the more interesting theories of genetic 
transmission suggests that the disorder is part of a broader 
Table 1 
Diagnostic Criteria for the Attention Deficit Disorder* 
Inattention (at least three ofthe following):t 
Fails to finish what is started 
Fails to listen 
Easily distracted 
Difficulty concentrating on schoolwork or other tasks requiring sustained 
attention 
Difficulty remaining with a play activity 
Impulsivity (at least three of the following):! 
Acts before thinking 
Difficulty organizing work (not due to cognitive impairment) 
Needs much supervision 
Frequently calls out in class 
Difficulty awaiting tura in games or group simations 
Hyperactivity (at least two of the following):! 
Runs about or climbs excessively 
Difficulty sitting still or fidgets excessively 
Difficulty staying seated 
Moves about excessively during sleep 
Always "on the go" or acts as i f "driven by a motor" 
Onset before age 7 
Duration at least six months 
Not due to schizophrenia, affective disorder, or severe or profound mental 
retardation 
*From American Psychiatric Associalion. Diagnostic and statistical manual of mental 
dfsorders. 3rd ed. Washinglon. DC: American Psychiatric Associalion. 1980. 
tThe number of symptoms specilied is for children between ages 8 and 10. the peak age 
range for referral. In younger children, more severe forms of the symptoms and a greater 
number of symptoms are usually present. The opposile is true in older children. 
constellation of disinhibitory conditions (eg, alcoholism, psy-
chopathy, hysteria, antisocial behavior, and impulsive person-
ality) (18). 
Constitutional 
Thomas and Chess (19,20) suggested infant temperament as a 
possible cause of attention deficit behavior The numerous tem-
perament styles delineated are assumed to reflect normal genetic 
variation in the expression of behavior. Theoretically, the behav-
iors delineating the ADD are reflective of constitutionally-based 
temperament patterns. The absence ofany convincing patho-
physiologic process in most children with the disorder makes 
the study of temperament pattems particularly interesting. Un-
fortunately, the methodological problems inherent in the study 
of temperament make it difficult, if not impossible, to make 
conclusive etiologic statements. 
Food additives 
In the 1970s, food additives were proposed as a major cause of 
the ADD in children. Conners (21) cast significant doubt on the 
validity of food additives as a relevant etiologic factor At best, 
an extremely small percentage of children (3% or less) may 
manifest attention deficit behaviors secondary to problems with 
the metabolism of food additives. During the 1980s, studies 
were conducted on the role of sugar as a cause of these behav-
iors, but the results do not support such a relationship. Allergies, 
particularly food allergies, also have been suggested as a cause, 
but no convincing evidence has been reported (22). 
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Child-rearing patterns 
Child-rearing approaches have been implicated as a cause of 
attention deficit behaviors, as well as parents who serve as po-
tential primary role models for the imitation of such behaviors 
(2). Whether such experiences are sufficient to produce the 
ADD is unknown. 
Social and emotional adjustment problems 
Most clinicians realize that attention deficit behaviors can be 
present in children with primary emotional disturbances, acute 
stress, and/or conflict and tension within the family. However, it 
is unclear whether such problems can, by themselves, produce a 
child with the disorder Attention deficit behaviors secondary to 
these psychosocial problems can lead to an erroneous diagnosis 
of the ADD and inappropriate management of the child's 
problems. 
Academic failure and frustration 
While attention deficit behaviors can interfere with optimal 
school performance, primary leaming problems may also give 
rise to emotional lability, fmstration, reduced motivation, and 
subsequently to attention deficit behaviors (5). In my opinion, 
many children with learning difficulties are misdiagnosed as 
having the ADD. 
TVeatment 
Medication 
Despite recent controversy over the use of stimulants in chil-
dren with the ADD (23), stimulant medication is the most com-
mon treatment approach and probably the most effective as a 
symptom-suppression agent. Yet positive response to stimulant 
medication is not a confirmation of the diagnosis. Studies show 
that approximately seven of ten children, adolescents, or adults 
who are given stimulants will show improvement of the target 
behaviors for which stimulant medication is administered (ie, 
hyperactivity, inattention, distractibility, and impulsivity) 
(22,24). Beyond this base-rate responsiveness to stimulant med-
ication, no single or multiple predictors can gauge respon-
siveness to stimulants. It was formerly thought that attention 
deficit behavior secondary to central nervous system damage 
could be reduced more effectively with antipsychotic med-
ications than with stimulants, but no convincing evidence has 
been presented. Nor is there evidence that the use of stimulants 
etiminates (ie, cures the child of) attention deficit behaviors. 
Stimulants cannot teach the child how to behave in a socially, 
interpersonally, or academically adaptive manner, even though 
they may facilitate improved functioning in these areas. These 
types of skills must be leamed. 
The most commonly used stimulants are methylphenidate hy-
drochloride, dextroamphetamine sulfate, and pemoline. Meth-
ylphenidate hydrochloride and dextroamphetamine sulfate are 
essentially equal in their overall effectiveness and reported side 
effects, although dextroamphetamine sulfate is thought to sup-
press appetite more than methylphenidate hydrochloride. 
Pemoline is less effective than the other two but has similar side 
effects. Other psychotropic medications have been used, nota-
bly antipsychotics and antidepressants, but with less success 
(14,25). Methylphenidate hydrochloride (5, 10, and 20 mg) and 
dextroamphetamine sulfate (5 mg) tablets are relatively quick 
acting (within 30 to 40 minutes) and of short duration (three to 
four hours). Methylphenidate hydrochloride also is available as 
a time-release preparation (20 mg slow release) which is effec-
tive for approximately eight hours, while the dextroamphet-
amine sulfate time-release preparation (5, 10, and 15 mg) is 
effective for approximately 12 hours. Pemoline (18.75, 37.50, 
and 75 mg) is administered once daily but requires two to three 
weeks of continuous administration before a therapeutic effect is 
noted. The development of tolerance to stimulant medication is 
rare (25). Preschool children (aged 3 to 5 years) need higher 
doses per kilogram of body weight than elementary school chil-
dren (aged 6 to 12 years), and adolescents need lower doses per 
kilogram of body weight than elementary school children. In 
general, children under age 3 do not benefit from the use of stim-
ulants. Approximately 50% of children aged 3 to 5 years who 
are given stimulants benefit from them, and approximately 75% 
of the children aged 6 years and older respond positively to med-
ication (5). Although preschool children are less likely to benefit 
from stimulant medication and are more likely to exhibit side 
effects than older children (26), the use of stimulants in these 
children is widespread (8) and potentially beneficial in some 
cases (26,27). The most commonly recommended initial and 
maximum daily dosages of these medications are presented in 
Table 2. 
Numerous texts provide comprehensive discussions of treat-
ment side effects (5,8,28). The two most commonly reported 
side effects of stimulants are appetite suppression and insomnia. 
Safer and Allen (29) reported supression of height and weight 
with chronic use of stimulants. However, subsequent research 
suggested that such suppression occurs most commonly in doses 
above 1 mg/kg/day with methylphenidate hydrochloride and at 
half this level with dextroamphetamine sulfate (30). Gross (31) 
noted that the suppressive effect is minimal over time and is 
often followed by a rebound effect when treatment is stopped. In 
a well-controlled study, McNutt and colleagues (32) found no 
evidence of suppression in height or weight over one year of 
treatment. Thus, as Campbell et al (33) noted, the controversy 
on the issue of height and weight suppression as a secondary fea-
ture to treatment with stimulants continues. Insomnia occurs 
most often when stimulants are given in the late aftemoon. Hy-
perirritability and emotional lability, other potential side effects, 
are especially prominent as the medication wears off or as dos-
age is increased. These side effects can interfere significantly 
with the child's general behavioral, social, and academic per-
formance. They can be misinterpreted as a need for more medi-
cation which, if given, only intensifies the negative effects. 
There is no evidence that stimulants are addictive or that they 
have long-term negative side effects as do the antipsychotic 
dmgs (22). Psychotic reactions reportedly occur most often with 
dosages within the recommended therapeutic range, but these 
reactions have been infrequent (5,34). The physical and/or psy-
chologic side effects of stimulant medication are minimal com-
pared to those of all other psychotropic medications (8,35). 
There are potential indirect psychosocial effects of stimulant 
medication use. For example, children on medication might as-
sume their behavior is solely a function of the "pil l" and hence 
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feel no sense of personal responsibility for their behavior. Some 
children dislike taking the medication and feel they are "weird." 
The child's perceptions, as well as those of his/her parents and 
teachers, are important factors to consider when stimulant medi-
cation treatment is considered. Whalen and Henker (36) re-
viewed the psychosocial issues surrounding the use of stimulant 
medication with children. 
While stimulant medication is a reasonable treatment ap-
proach, the conditions under which it should be recommended 
need to be identified. Some children with the ADD function well 
socially and academically. Should such children be given medi-
cation simply to make them less restless and more attentive? 
What should be done if parents refuse to give medication to their 
child, despite the appropriateness of the diagnosis of ADD? Do 
physicians, educators, and mental health professionals have the 
right to pressure parents to give their child the medication? Un-
fortunately, there is no singularly accepted or unambiguous set 
of guidelines to answer these questions. Guidelines published 
by the Committee on Children with Disabilities/Committee on 
Drags (37) describe such issues as choice of medication, dos-
age, and the importance of altemative or adjunct treatment(s), 
but do not provide insight about whether or not to treat the child 
with stimulant medication. 
Psychological behavior therapy 
The efficacy of individual psychotherapy has been questioned 
for many childhood disorders (22), and no convincing evidence 
exists regarding the utility of such an approach with children 
who present with the ADD. Behavior therapy approaches have 
not fared much better (38). Educating parents and teachers on 
how to manage and help these children to function more appro-
priately may be far more important. 
Outcome 
In their review of the outcome of the ADD, Weiss and 
Hechtman (3) concluded that: 1) core symptoms (restlessness, 
attention difficulties, and impulsivity) tended to persist in ado-
lescence and adulthood, although they may be manifested 
somewhat differently and less intensely; 2) a significant percent-
age (approximately 25%) of adolescents with a history of atten-
tion deficit behaviors manifested antisocial behavior; 3) both 
children and adolescents with a history of attention deficit be-
haviors had more problems with self-esteem, social skills, and 
impulsivity than control subjects; 4) while symptoms may con-
tinue into adulthood, most studies indicated that a substantial 
proportion of subjects (30% to 50%) displayed behavior indis-
tinguishable from normal adults; and 5) approximately 20% to 
25% of the adults had significant drag and/or alcohol problems 
and/or significant antisocial behavior 
Outcome is most likely related to the following factors: I) in-
tensity of symptoms, 2) social adaptability, 3) intelligence and 
academic achievement levels, 4) stability of the family, 5) 
the parents' ability to manage the child's attention deficit behav-
iors, 6) social/emotional adjustment of the parents, and 7) the 
ability of school personnel to manage the child's attention 
deficit behaviors. 
Table 2 
Medication for Children with the Attention Deficit 
Disorder* 
Starting Maximum 
Drag Dose Dose 
Methylphenidate hydrochloride 0.30 mg/kg I.OO mg/kg 
Dextroamphetamine sulfate 0.15 mg/kg 0.50 mg/kg 
Pemoline 0.50 mg/kg 2.00 mg/kg 
*From Donnelly M. Rapoport JL. Attention deficit disorders. In: Wiener JM. ed. Diag-
nosis and psychopharmacology of childhood and adolescent disorders. New York: John 
Wiley. 1985. 
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